UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of bezlotoxumab for prevention of recurrent Clostridium difficile infection (CDI) in Japanese patients

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018-02, Vol.24 (2), p.123-129

2018

Volltextzugriff (PDF)

The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicated intra-abdominal infections

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019-02, Vol.25 (2), p.111-116

2019

Volltextzugriff (PDF)

The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019-02, Vol.25 (2), p.104-110

2019

Volltextzugriff (PDF)

Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013-06, Vol.19 (3), p.447-455

2013

Volltextzugriff (PDF)

Evaluation of the safety, tolerability, and pharmacokinetics of a single bolus injection of daptomycin in healthy Japanese subjects

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015-03, Vol.21 (3), p.170-175

2015

Volltextzugriff (PDF)

Pharmacokinetics, efficacy, and safety of caspofungin in Japanese pediatric patients with invasive candidiasis and invasive aspergillosis

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015-06, Vol.21 (6), p.421-426

2015

Volltextzugriff (PDF)

Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha- ras-transformed NIH 3T3 cells

Biochemical and biophysical research communications, 1988-11, Vol.157 (1), p.183-189

1988

Volltextzugriff (PDF)

Correlation between pharmacokinetic/pharmacodynamic indices and clinical outcomes in Japanese patients with skin and soft tissue infections treated with daptomycin: analysis of a phase III study

Diagnostic microbiology and infectious disease, 2015-09, Vol.83 (1), p.77-81

2015

Volltextzugriff (PDF)

Therapeutic activity of the topoisomerase I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxy) ethylamino-12,13-dihydro-13-(β-d-gluco pyranosyl)-5H-indolo[2,3-a]-pyrrolo[3,4-c]-carbazole-5,7(6h)-dione] against pediatric and adult central nervous system tumor xenografts

Cancer chemotherapy and pharmacology, 2001-09, Vol.48 (3), p.250-254

2001

Volltextzugriff (PDF)

Automatic acquisition for sensibility knowledge using co-occurrence relation

International journal of computer applications in technology, 2008-01, Vol.33 (2/3), p.218

2008

Volltextzugriff (PDF)

A method for extracting knowledge from medical texts including numerical representation

International journal of computer applications in technology, 2008-01, Vol.33 (2/3), p.226

2008

Volltextzugriff (PDF)

Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue

Cancer research (Chicago, Ill.), 1997-06, Vol.57 (11), p.2151-2156

1997

Volltextzugriff (PDF)

A NEW ANTITUMOR SUBSTANCE, BE-13793C, PRODUCED BY A STREPTOMYCETE: TAXONOMY, FERMENTATION, ISOLATION, STRUCTURE DETERMINATION AND BIOLOGICAL ACTIVITY

The Journal of Antibiotics, 1991/07/25, Vol.44(7), pp.723-728

1991

Volltextzugriff (PDF)

A NEW TOPOISOMERASE II INHIBITOR, BE-22179, PRODUCED BY A STREPTOMYCETE: I. PRODUCING STRAIN, FERMENTATION, ISOLATION AND BIOLOGICAL ACTIVITY

The Journal of Antibiotics, 1994/02/25, Vol.47(2), pp.129-135

1994

Volltextzugriff (PDF)

A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2007-01, Vol.59 (1), p.139-147

2007

Volltextzugriff (PDF)

Mode of action of a new indolocarbazole anticancer agent, J-107088, targeting topoisomerase I

Cancer research (Chicago, Ill.), 1999-09, Vol.59 (17), p.4271-4275

1999

Volltextzugriff (PDF)

A NEW TOPOISOMERASE-II INHIBITOR, BE-10988, PRODUCED BY A STREPTOMYCETE: I. TAXONOMY, FERMENTATION, ISOLATION AND CHARACTERIZATION

The Journal of Antibiotics, 1991/05/25, Vol.44(5), pp.486-491

1991

Volltextzugriff (PDF)

Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents

Cancer research (Chicago, Ill.), 1999-06, Vol.59 (12), p.2853-2860

1999

Volltextzugriff (PDF)

Novel indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11-dihydroxy- 13-(beta-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo-[3,4-c]carbazole- 5,7(6H)-dione (NB-506): its potent antitumor activities in mice

Cancer research (Chicago, Ill.), 1995-03, Vol.55 (6), p.1316

1995

Volltextzugriff (PDF)

Synthesis and biological activities of NB-506 analogues modified at the glucose group

Bioorganic & medicinal chemistry letters, 2000-03, Vol.10 (5), p.419-422

2000

Volltextzugriff (PDF)

Novel antitumor indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13-(β-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506) : induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity

Cancer research (Chicago, Ill.), 1995-03, Vol.55 (6), p.1310-1315

1995

Volltextzugriff (PDF)

Substitution at the F-Ring N-Imide of the Indolocarbazole Antitumor Drug NB-506 Increases the Cytotoxicity, DNA Binding, and Topoisomerase I Inhibition Activities

Journal of medicinal chemistry, 1999-07, Vol.42 (15), p.2927-2935

1999

Volltextzugriff (PDF)

Synthesis and biological activities of NB-506 analogues: Effects of the positions of two hydroxyl groups at the indole rings

Bioorganic & medicinal chemistry letters, 1999-12, Vol.9 (23), p.3307-3312

1999

Volltextzugriff (PDF)

Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110

Cancer research (Chicago, Ill.), 1993-02, Vol.53 (3), p.490-494

1993

Volltextzugriff (PDF)

Sequence‐selective DNA cleavage by a topoisomerase I poison, NB‐506

International journal of cancer, 1998-01, Vol.75 (1), p.145-150

1998

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(138)

Publikationsform

Sprache

Englisch
(146)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(98)
Life Sciences & Biomedicine
(87)
Humans
(75)
Female
(54)
Biological And Medical Sciences
(36)
Animals
(32)
Male
(31)
Medical Sciences
(30)
Adult
(27)
Middle Aged
(25)
Oncology
(23)
Aged
(21)
Mice
(21)
Pharmacology. Drug Treatments
(19)
Antineoplastic Agents
(18)
Pharmacology & Pharmacy
(17)
Tumor Cells, Cultured
(14)
Antineoplastic Agents - Pharmacology
(13)
Biochemistry & Molecular Biology
(13)
Carbazoles - Pharmacology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of bezlotoxumab for prevention of recurrent Clostridium difficile infection (CDI) in Japanese patients

The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicated intra-abdominal infections

The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection

Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections

Evaluation of the safety, tolerability, and pharmacokinetics of a single bolus injection of daptomycin in healthy Japanese subjects

Pharmacokinetics, efficacy, and safety of caspofungin in Japanese pediatric patients with invasive candidiasis and invasive aspergillosis

Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha- ras-transformed NIH 3T3 cells

Correlation between pharmacokinetic/pharmacodynamic indices and clinical outcomes in Japanese patients with skin and soft tissue infections treated with daptomycin: analysis of a phase III study

Therapeutic activity of the topoisomerase I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxy) ethylamino-12,13-dihydro-13-(β-d-gluco pyranosyl)-5H-indolo[2,3-a]-pyrrolo[3,4-c]-carbazole-5,7(6h)-dione] against pediatric and adult central nervous system tumor xenografts

Automatic acquisition for sensibility knowledge using co-occurrence relation

A method for extracting knowledge from medical texts including numerical representation

Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue

A NEW ANTITUMOR SUBSTANCE, BE-13793C, PRODUCED BY A STREPTOMYCETE: TAXONOMY, FERMENTATION, ISOLATION, STRUCTURE DETERMINATION AND BIOLOGICAL ACTIVITY

A NEW TOPOISOMERASE II INHIBITOR, BE-22179, PRODUCED BY A STREPTOMYCETE: I. PRODUCING STRAIN, FERMENTATION, ISOLATION AND BIOLOGICAL ACTIVITY

A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors

Mode of action of a new indolocarbazole anticancer agent, J-107088, targeting topoisomerase I

A NEW TOPOISOMERASE-II INHIBITOR, BE-10988, PRODUCED BY A STREPTOMYCETE: I. TAXONOMY, FERMENTATION, ISOLATION AND CHARACTERIZATION

Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents

Novel indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11-dihydroxy- 13-(beta-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo-[3,4-c]carbazole- 5,7(6H)-dione (NB-506): its potent antitumor activities in mice

Synthesis and biological activities of NB-506 analogues modified at the glucose group

Novel antitumor indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13-(β-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506) : induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity

Substitution at the F-Ring N-Imide of the Indolocarbazole Antitumor Drug NB-506 Increases the Cytotoxicity, DNA Binding, and Topoisomerase I Inhibition Activities

Synthesis and biological activities of NB-506 analogues: Effects of the positions of two hydroxyl groups at the indole rings

Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110

Sequence‐selective DNA cleavage by a topoisomerase I poison, NB‐506

Suchergebnisse filtern